Package 60505-2521-8

{"route": ["ORAL"], "spl_id": "855689c6-1a9b-a366-dcc4-e6a1c04ff25a", "openfda": {"nui": ["N0000175598", "N0000175086"], "upc": ["0360505252213"], "unii": ["N7Z035406B"], "rxcui": ["242461", "242462"], "spl_set_id": ["ceac1ae3-c343-28ca-c083-b748d21a15e6"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (60505-2521-1)", "package_ndc": "60505-2521-1", "marketing_start_date": "20111018"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (60505-2521-3)", "package_ndc": "60505-2521-3", "marketing_start_date": "20111018"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (60505-2521-8)", "package_ndc": "60505-2521-8", "marketing_start_date": "20111018"}], "brand_name": "cilostazol", "product_id": "60505-2521_855689c6-1a9b-a366-dcc4-e6a1c04ff25a", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "60505-2521", "generic_name": "cilostazol", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "50 mg/1"}], "application_number": "ANDA077030", "marketing_category": "ANDA", "marketing_start_date": "20111018", "listing_expiration_date": "20261231"}